Citadel Advisors’s Vaxcyte PCVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-326,574
Closed -$17.7M 14092
2025
Q4
$15.1M Buy
326,574
+120,775
+59% +$5.4M 0.01% 2696
2025
Q3
$7.41M Sell
205,799
-884,939
-81% -$29.3M 0.01% 3700
2025
Q2
$35.5M Buy
1,090,738
+994,351
+1,032% +$32.6M 0.03% 1526
2025
Q1
$3.64M Sell
96,387
-45,394
-32% -$3.63M ﹤0.01% 4423
2024
Q4
$11.6M Buy
141,781
+135,914
+2,317% +$13.5M 0.01% 2796
2024
Q3
$670K Buy
+5,867
New +$529K ﹤0.01% 7646
2024
Q2
Sell
-119
Closed -$8.1K 15160
2024
Q1
$8.13K Buy
+119
New +$8.24K ﹤0.01% 13573
2023
Q4
Sell
-22,106
Closed -$1.15M 15049
2023
Q3
$1.13M Buy
+22,106
New +$1.09M ﹤0.01% 6321
2023
Q2
Sell
-854,110
Closed -$40.5M 15056
2023
Q1
$32M Buy
854,110
+2,252
+0.3% +$95.5K 0.04% 1475
2022
Q4
$40.8M Buy
851,858
+18,991
+2% +$745K 0.05% 1289
2022
Q3
$20M Sell
832,867
-170,119
-17% -$4.31M 0.02% 1877
2022
Q2
$21.8M Buy
1,002,986
+285,031
+40% +$6.6M 0.03% 1755
2022
Q1
$17.3M Buy
717,955
+635,105
+767% +$13.9M 0.02% 2151
2021
Q4
$1.97M Buy
82,850
+37,116
+81% +$863K ﹤0.01% 6277
2021
Q3
$1.16M Sell
45,734
-48,263
-51% -$1.17M ﹤0.01% 7773
2021
Q2
$2.12M Sell
93,997
-16,840
-15% -$345K ﹤0.01% 6477
2021
Q1
$2.19M Sell
110,837
-83,974
-43% -$2.11M ﹤0.01% 6182
2020
Q4
$5.18M Buy
194,811
+142,252
+271% +$5.29M 0.01% 3621
2020
Q3
$2.6M Sell
52,559
-497,192
-90% -$19.8M ﹤0.01% 4246
2020
Q2
$17.4M Buy
+549,751
New +$17.7M 0.02% 1638

Other funds holding PCVX